Co-targeting Bulk Tumor and CSCs in Clinically Translatable TNBC Patient-Derived Xenografts via Combination Nanotherapy.
Sulaiman A, McGarry S, El-Sahli S, Li L, Chambers J, Phan A, Côté M, Cron GO, Alain T, Le Y, Lee SH, Liu S, Figeys D, Gadde S, Wang L.
Sulaiman A, et al. Among authors: wang l.
Mol Cancer Ther. 2019 Oct;18(10):1755-1764. doi: 10.1158/1535-7163.MCT-18-0873. Epub 2019 Jul 15.
Mol Cancer Ther. 2019.
PMID: 31308079